Thursday, May 21, 2026

9:30 AM - 10:15 AM

---

Details

Global politics shifts and changes to trade policy and priorities can influence how medtech companies collaborate globally, operate, manufacture and export. As governments place greater focus on supply chain security and domestic manufacturing, there is increasing attention on where medtech products are made, sourced and imported. This session provides an overview of what is changing and why it may matter for Australian medtech companies. Led by AusBiotech, it will outline the current geopolitical landscape and explore what this could mean in practice, drawing on company perspectives on managing risk, costs and supply chain decisions, as well as seizing the opportunities of the changing global environment.

---

Speaker